Momenta Pharmaceuticals (MNTA) September volatility elevated at 125
Tweet Send to a Friend
Momenta Pharmaceuticals (Nasdaq: MNTA) closed at $16.99. On July 23 the FDA said it approved a generic version of Lovenox ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


